administered in daily doses of 160 to 1,500 mg , acetylsalicylic acid reduces the frequency of coronary thrombosis and its consequence , myocardial infarction , in the following clinical situations : year following myocardial infarction , acute phase of myocardial infarction , unstable angina , year following aorto-coronary bypass , days following dilatation of the coronary arteries .
C0004057
acetylsalicylic acid
C0027051
myocardial infarction